OTCMKTS:APNHY Aspen Pharmacare (APNHY) Stock Price, News & Analysis $10.05 0.00 (0.00%) As of 09/21/2026 09:50 AM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartDividendNews and TrendsShort Interest About Aspen Pharmacare Stock (OTCMKTS:APNHY) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Aspen Pharmacare alerts:Sign Up Key Stats Today's Range$10.00▼$10.0550-Day Range$8.61▼$10.0552-Week Range$5.24▼$10.05Volume26,001 shsAverage Volume1,483 shsMarket Capitalization$4.48 billionP/E RatioN/ADividend Yield0.70%Price TargetN/AConsensus RatingN/A Company Overview Aspen Pharmacare Holdings Limited is a South African pharmaceutical company that develops, manufactures and supplies branded and generic medicines, active pharmaceutical ingredients and consumer health products. Its portfolio spans therapeutic areas including anesthesia, thrombosis, respiratory care, gastroenterology, cardiovascular medicine, women’s health and other hospital and primary-care treatments. The company also provides pharmaceutical manufacturing services for third-party customers, including the production of sterile medicines, vaccines and other complex pharmaceutical products. Aspen has developed capabilities in areas such as biologics and active pharmaceutical ingredients, supporting both its own product portfolio and partnerships with international healthcare companies. Founded in South Africa in 1850, Aspen has expanded into an international healthcare group serving markets across Africa, Europe, Asia, the Americas and other regions. The company operates through a network of manufacturing and commercial operations and has historically focused on increasing access to medicines in emerging and developed markets. Stephen Saad is Aspen’s founder and chief executive officer.AI Generated. May Contain Errors. Read More Receive APNHY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Aspen Pharmacare and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. APNHY Stock News HeadlinesAspen Pharmacare Earnings Call Signals Cash-Fueled ComebackSeptember 15, 2026 | tipranks.comAspen Pharmacare Holdings Ltd ADR APNHYSeptember 3, 2026 | morningstar.comMYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time through a temporary download link. He plans to charge for it soon. Download your copy now and lock it in at no cost, regardless of future pricing.September 23 at 1:00 AM | Profits Run (Ad)Aspen Pharmacare Holdings Limited (APNHY) Q4 2026 Earnings Call TranscriptSeptember 3, 2026 | seekingalpha.comMerck signs licensing deals with companies including Viatris for new HIV pillJuly 24, 2026 | seekingalpha.comAspen Joins Africa Push to Make MSD’s HIV Prevention PillJuly 24, 2026 | financialpost.comFAspen Pharmacare Holdings Limited (APNHY) Shareholder/Analyst Call Prepared Remarks TranscriptMay 29, 2026 | seekingalpha.comAspen Pharmacare Holdings Insider Ups Holding During YearApril 3, 2026 | finance.yahoo.comSee More Headlines APNHY Stock Analysis - Frequently Asked Questions How have APNHY shares performed this year? Aspen Pharmacare's stock was trading at $6.5848 at the start of the year. Since then, APNHY stock has increased by 52.6% and is now trading at $10.05. How do I buy shares of Aspen Pharmacare? Shares of APNHY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Today9/23/2026Fiscal Year End6/30/2027Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolOTCMKTS:APNHY Previous SymbolNASDAQ:APNHY CIK1454177 Webwww.aspenpharma.com Phone(731) 580-8600Fax27-11-239-6144Employees9,557Year Founded1850Profitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio0.36 Current Ratio3.64 Quick Ratio2.66 Sales & Book Value Annual Sales$2.07 billion Price / Sales2.17 Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares446,250,000Free FloatN/AMarket Cap$4.48 billion OptionableNot Optionable Beta0.75 Social Links The 7 Hottest IPO Stories of 2026MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.Get This Free Report This page (OTCMKTS:APNHY) was last updated on 9/23/2026 by MarketBeat.com Staff. From Our PartnersALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredThe end may be near for these iconic stocksMarc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are ...Chaikin Analytics | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredHere’s Why Trump Won’t End The Iran WarTrump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...Banyan Hill Publishing | SponsoredThese gold assets are priced for $1,800 gold [it's over $4,000]Gold's major miners are generating record free cash flow, with margins as high as 75 percent even after gold's...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aspen Pharmacare Please log in to your account or sign up in order to add this asset to your watchlist. Share Aspen Pharmacare With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free APNHY Stock Alerts